17020-22-3

Basic information

• Product Name: 3β-Hydroxyolean-12-en-28-al
• Synonyms: 3β-Hydroxyolean-12-en-28-al;Oleanic aldehyde;Oleanolic aldehyde;3beta-Hydroxyolean-12-en-28-aldehyde;Oleanolaldehyde
• CAS NO: 17020-22-3
• Molecular Formula: C₃₀H₄₈O₂
• Molecular Weight: 440.7
• Mol File: 17020-22-3.mol
• Article Data: 6

Chemical Properties

• Melting Point: 169-172℃
• Boiling Point: 516.5±50.0 °C(Predicted)
• Appearance: /
• Density: 1.05±0.1 g/cm3(Predicted)
• PKA: 15.16±0.70(Predicted)
• CAS DataBase Reference: 3β-Hydroxyolean-12-en-28-al(CAS DataBase Reference)
• NIST Chemistry Reference: 3β-Hydroxyolean-12-en-28-al(17020-22-3)
• EPA Substance Registry System: 3β-Hydroxyolean-12-en-28-al(17020-22-3)

Safety Data

• Hazardous Substances Data: 17020-22-3(Hazardous Substances Data)

Usage

Description

3β-Hydroxyolean-12-en-28-al, also known as erythrodiol, is a pentacyclic triterpenoid and hydroxyaldehyde that is derived from the oxidation of the primary hydroxy group at position 28. It is a naturally occurring compound found in grapes and olives.

Uses

Used in Pharmaceutical Industry:
3β-Hydroxyolean-12-en-28-al is used as a pharmaceutical compound for its potential therapeutic properties. It has been studied for its anti-inflammatory, anti-viral, and anti-cancer effects, making it a promising candidate for the development of new drugs.
Used in Cosmetic Industry:
3β-Hydroxyolean-12-en-28-al is used as an active ingredient in cosmetics for its potential skin health benefits. It has been reported to have anti-aging, moisturizing, and skin brightening properties, making it a valuable component in skincare products.
Used in Food Industry:
3β-Hydroxyolean-12-en-28-al is used as a natural additive in the food industry for its potential health benefits. It has been found to have antioxidant properties, which can help protect against oxidative stress and support overall health.
Used in Nutraceutical Industry:
3β-Hydroxyolean-12-en-28-al is used as a nutraceutical ingredient for its potential health-promoting effects. It has been studied for its ability to support cardiovascular health, improve liver function, and enhance immune system function, making it a valuable component in dietary supplements.

Upstream product

• 545-48-2 erythrodiol 
• 508-02-1 Oleanolic acid 
• 197500-50-8 (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-(tert-Butyl-dimethyl-silanyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid methyl ester 
• 152487-61-1 (3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-olean-12-en-28-ol 
• 1724-17-0 oleanolic acid methyl ester 

Downstream Products

• 545-48-2 erythrodiol 

Relevant articles and documents

COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY

The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.

9-azanoradamantane N—oxyl compound and method for producing same, and organic oxidation catalyst and method for oxidizing alcohols using 9-azanoradamantane N—oxyl compound

An organocatalyst for oxidizing alcohols in which a primary alcohol is selectively oxidized in a polyol substrate having a plurality of alcohols under environmentally-friendly conditions. The organic oxidation catalyst has an oxygen atom bonded to a nitrogen atom of an azanoradamantane skeleton and at least one alkyl group at positions 1 and 5. The oxidation catalyst has higher activity than TEMPO, which is an existing oxidation catalyst, in the selective oxidation reaction of primary alcohols, and better selectivity than AZADO and 1-Me-AZADO. This DMN-AZADO can be applied to the selective oxidation reaction of primary alcohols that contributes to shortening the synthesizing process for pharmaceuticals, pharmaceutical raw materials, agricultural chemicals, cosmetics, organic materials, and other such high value-added organic compounds.

C17-ALKANEDIYL AND ALKENEDIYL DERIVATIVES OF OLEANOLIC ACID AND METHODS OF USE THEREOF

Disclosed herein are novel C17-alkanediyi and aikenediyl derivatives of oleanolic acid, including those of the formula (I), wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds, for example, as antioxidant inflammation modulators, and compositions thereof are also provided.